Ivosidenib is currently covered by medical insurance or is it completely self-pay?

Ivosidenib is a targeted drug used to treat specific types of acute myeloid leukemia (AML) and cholangiocarcinoma. It has been officially launched in China. However, due to its relatively short time on the market, the drug has not yet been included in the national medical insurance catalog. Therefore, if patients need to use ivonib for treatment, they usually need to bear all the drug costs themselves, which is completely self-pay. This may bring a certain burden to patients with long-term treatment or limited financial conditions.

In the domestic market, the original drug price of ivonib is relatively high, with the price of each box generally ranging from RMB 30,000 to RMB 40,000. The specific cost may vary slightly due to dosage, course of treatment and regional differences. Patients can go to a qualified hospital pharmacy for detailed consultation before purchasing medicines in order to obtain accurate quotations and usage suggestions. At present, domestic original drugs are mostly introduced through formal channels, with stable quality assurance and clear medication guidance.

For patients with a heavy financial burden, they may also consider purchasing generic versions of ivonib through overseas channels. Currently, the more common drug on the market is the Lao version of the generic version of Avosidenib, which is relatively affordable, with each box costing about more than 3,000 yuan. Although this version is not the original drug, its ingredients and efficacy are basically the same, and it is favored by many patients. However, when choosing to purchase drugs overseas, patients need to pay attention to the formality of the channels to ensure the quality and safety of the drugs.

In short, although avosidenib has been marketed in China, it has not yet entered the medical insurance reimbursement system, and patients still need to bear the full cost. For patients who need medicine, it is very important to understand the different drug purchase channels and price differences. At the same time, it is recommended to rationally choose a medication regimen under the guidance of a doctor, taking into account both efficacy and affordability, in order to achieve the best treatment effect.

Reference link:https://www.tibsovo.com/